Portage Biotech Long Term Debt

Portage Biotech (PRTG) currently reports a long-term debt of $0 as of March 2025. That compares with $7K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Portage Biotech's long-term debt history and peer comparisons.

Portage Biotech's long-term debt decreased from $7K to $0 — a 100.0% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Portage Biotech reported $0 in long-term debt as of March 2025. That compares with $7K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Portage Biotech, and consider following PRTG for alerts when major investors trade the stock.

Portage Biotech is classified in the Energy sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Energy are usually more informative than comparing PRTG with unrelated industries.